[BetterSeeds in The Jerusalem Post] New Collaboration to validate CRISPR Genome-editing tools in plants

Merck KGaA, a leading multinational Pharmaceutical company, has signed through its Life Science division, MilliporeSigma, a unique collaboration and license agreement with an Israeli AgTech company to demonstrate the utility of its proprietary CRISPR genome-editing tools in agricultural uses. The agreement licenses its foundational CRISPR intellectual property to Israeli BetterSeeds Ltd., a disruptive company that uses genome editing technology including CRISPR to develop new breeds of plants.

Read more here.